ArticlePharmaceutics2023

Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders.

Agata Górniak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.